1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow LY2812223: new trials by email Literature Review of LY2812223 trials Research Report on LY2812223
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression MP-101, Placebo - Psychosis, Dementia | Phase 2 | Terminated | Mediti Pharma Inc. | 81 | 2017-05-04 | 2021-04-01 |
Aggression (1) · Alzheimer Disease (1) · Dementia (1) · Psychomotor Agitation (1) · Psychotic Disorders (1)
Canada (1) · United States (1)